Chapter 368dd - OFFICE OF HEALTH STRATEGY
- Section 19a-750 to 19a-754 - [Repealed]
- Section 19a-754a - Office of Health Strategy established
- Section 19a-754b - Notices to office re sponsor applications to the Food and Drug Administration. Studies of pharmaceutical manufacturers and outpatient prescription drugs. Penalty. Regulations
- Section 19a-754c - Covered Connecticut program
- Section 19a-754d - Collection of demographic data re ancestry or ethnic origin, ethnicity, race or primary language. Inclusion in electronic health record systems
- Section 19a-754e - Health care expansion study. Report
- Section 19a-754f - Definitions
- Section 19a-754g - [Effective Until 10/1/2024] Health care cost growth benchmarks and annual primary care spending targets
- Section 19a-754g - [Effective 10/1/2024] Health care cost growth benchmarks and annual primary care spending targets
- Section 19a-754h - Report
- Section 19a-754i - Health care quality benchmarks
- Section 19a-754j - Informational public hearing
- Section 19a-754k - Regulations